- Novartis (NVS +1.2%) may consider selling its animal-health business as part of a portfolio review the company is conducting with the help of Goldman, people familiar with the matter tell Bloomberg.
- Although no decisions are final, the sources also suggest the OTC medicines business and the vaccines unit are also candidates for a possible sale.
- According the Cit estimates, the animal-health business is worth around $4B.
Novartis considering sale of animal-health, OTC drug, vaccine businesses: Bloomberg
Nov 4 2013, 14:00 ET